Walleye Trading LLC Immunovant, Inc. Put Options Transaction History

Walleye Trading LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$30.27 - $43.79 $39,351 - $56,927	-1,300 Reduced 86.67%	200 $6,000
Q4 2023 Feb 14, 2024	BUY	$31.31 - $44.19 $28,179 - $39,771	900 Added 150.0%	1,500 $63,000
Q3 2023 Nov 14, 2023	BUY	$18.55 - $39.96 $11,130 - $23,976	600 New	600 $23,000
Q4 2022 Feb 14, 2023	BUY	$6.59 - $17.75 $6,590 - $17,750	1,000 New	1,000 $17,000
Q3 2021 Nov 15, 2021	SELL	$7.01 - $11.37 $35,050 - $56,849	-5,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$9.4 - $16.85 $47,000 - $84,250	5,000 New	5,000 $53,000

211

66.9M

2.3M

631K

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.